JLR report profitable quarter despite fall in sales
It has been a busy 12 months for the company, with a highly publicised rebranding late in 2024, followed by problems off the back of US president Donald Trump's controversial trade tariffs - there has also been gradual phase-out of older Jaguar models which have also contributed to fall in profits compared to the previous year.
The latest quarterly figures have been announced days after it was revealed CEO Adrian Mardell would be retiring. But there are plenty of positives too - JLR has welcomed a new UK-US trade deal that has cut tariffs on UK-built cars exported to the US from 27.5 percent to 10 percent, which came into effect on 30 June. A separate EU-US agreement will also reduce tariffs on its EU-built cars in future.
Read more: Flats flooded after major water leak at Lower Precinct in Coventry
The company also announced last week Mr Mardell's successor, Mr P.B. Balaji will become CEO from November 2025 following Mr Mardell's departure
The quarter saw progress in the Coventry car maker's electrification plans, with media test drives of the new electric Range Rover and over 200 test builds of a new electric SUV at its Halewood plant. Special edition models were also launched across the Range Rover, Defender and Discovery ranges.
The company's earnings before interest and tax (EBIT) remains the same at 4 percent, slightly lower than the guidance range of 5 to 7 percent. Mr Mardell said the company would continue to invest in new models, including electric Jaguar and Range Rover vehicles, with £3.8 billion planned this year.
'Thanks to our talented people and the robust foundations we have built at JLR, we delivered an 11th successive profitable quarter amid challenging global economic conditions," he said "We are grateful to the UK and US Governments for delivering at speed the new UK-US trade deal, which will lessen the significant US tariff impact in subsequent quarters, as will, in due course, the EU-US trade deal announced on 27 July 2025.
"Looking ahead, we remain focused on delivering our transformational Reimagine Strategy, including investing £3.8 billion this financial year to support the development of our next-generation vehicles, including our stunning new electric Range Rover and Jaguar models."
Dr Charles Tennant, a local Automotive Analyst, said: "Another successful quarterly profit driven by high profit margin Range Rover and Defender sales.
"Unfortunately sales were down by 9.2% due to temporarily pausing vehicle shipments to America in April when tariffs were raised to an unsustainable level of 27.5 percent although that should settle down now that the UK - USA trade deal has been signed off at the 10 percent level.
"Looking ahead the EBIT profit margin forecast of between 5 percent to 7 percent for the full year is lower than the 10 percent originally planned but I'm sure JLR will be looking at how they can increase that for next year."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Undiscovered Gems in Asia to Explore This August 2025
As global markets navigate a complex landscape with shifting trade policies and interest rate adjustments, the Asian market stands out with its resilience, particularly in the face of U.S.-China trade dynamics. In this environment, identifying stocks that demonstrate robust growth potential and adaptability can be crucial for investors seeking to capitalize on emerging opportunities. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating DoshishaLtd NA 2.88% 2.08% ★★★★★★ CHT Security NA 11.39% 23.71% ★★★★★★ Kung Sing Engineering 13.45% 2.65% -51.67% ★★★★★★ FDK 89.05% 1.03% -12.00% ★★★★★☆ Uniplus Electronics 32.17% 46.30% 75.33% ★★★★★☆ Hunan Investment GroupLtd 4.50% 25.84% 15.32% ★★★★★☆ Nippon Ski Resort DevelopmentLtd 40.68% 13.17% 53.25% ★★★★★☆ BIOBIJOULtd 6.87% 72.99% 117.16% ★★★★★☆ Bank of Iwate 87.84% 1.47% 13.86% ★★★★☆☆ Lucky Cement 61.41% 4.55% 15.65% ★★★★☆☆ Click here to see the full list of 2533 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. Let's review some notable picks from our screened stocks. Shaanxi Sirui Advanced Materials Simply Wall St Value Rating: ★★★★☆☆ Overview: Shaanxi Sirui Advanced Materials Co., Ltd. operates in the advanced materials sector and has a market capitalization of approximately CN¥12.07 billion. Operations: The company generates revenue primarily from its advanced materials segment. It has a market capitalization of approximately CN¥12.07 billion, reflecting its scale in the sector. Shaanxi Sirui Advanced Materials, a smaller player in the metals and mining sector, showcases robust earnings growth of 20.5% over the past year, outpacing the industry average of -4.1%. The company's interest payments are comfortably covered by EBIT at 10x, indicating strong financial health despite a high net debt to equity ratio of 61%. While free cash flow remains negative with recent figures showing -A$153 million as of September 2024, there's potential for improvement given its forecasted annual earnings growth rate of nearly 30%. A recent shareholder meeting signals active engagement with stakeholders amid volatile share prices. Take a closer look at Shaanxi Sirui Advanced Materials' potential here in our health report. Explore historical data to track Shaanxi Sirui Advanced Materials' performance over time in our Past section. Cre8 Direct (NingBo) Simply Wall St Value Rating: ★★★★★☆ Overview: Cre8 Direct (NingBo) Co., Ltd. is a company that, along with its subsidiaries, focuses on designing, producing, processing, and selling paper products in North America and has a market capitalization of CN¥5.54 billion. Operations: Cre8 Direct generates revenue primarily from the sale of paper products, totaling CN¥2.07 billion. The company's financial performance is influenced by its ability to manage production costs and optimize profit margins in a competitive market. Cre8 Direct (NingBo) has demonstrated robust financial health with earnings surging by 31% over the past year, significantly outpacing the Forestry industry's -6.9%. The company enjoys a strong position with cash exceeding total debt, ensuring an appropriate debt level. Its interest payments are comfortably covered by EBIT at 239 times, highlighting solid financial management. Despite recent share price volatility, Cre8 Direct continues to deliver high-quality earnings and positive free cash flow. A recent dividend approval of CNY 1.50 per 10 shares underscores its commitment to shareholder returns while maintaining growth momentum in the competitive landscape. Navigate through the intricacies of Cre8 Direct (NingBo) with our comprehensive health report here. Evaluate Cre8 Direct (NingBo)'s historical performance by accessing our past performance report. Sanbo Hospital Management Group Simply Wall St Value Rating: ★★★★★☆ Overview: Sanbo Hospital Management Group Limited, along with its subsidiaries, specializes in hospital management in China and has a market capitalization of CN¥11.69 billion. Operations: Sanbo Hospital Management Group generates revenue primarily from its healthcare facilities and services, amounting to CN¥1.49 billion. The company's financial performance is highlighted by a net profit margin that reflects its operational efficiency within the hospital management sector in China. Sanbo Hospital Management Group, a small player in the healthcare sector, showcases impressive financial resilience. Its earnings growth of 26% over the past year outpaces the industry average of -9%, highlighting robust performance. Despite an increase in its debt to equity ratio from 3% to 7.4% over five years, Sanbo holds more cash than total debt, suggesting sound financial health. Interest payments are well covered by EBIT at a substantial 257 times coverage. The company recently approved a final cash dividend of CNY1.48 per ten shares, indicating confidence in its profitability and future prospects within the healthcare landscape. Dive into the specifics of Sanbo Hospital Management Group here with our thorough health report. Gain insights into Sanbo Hospital Management Group's historical performance by reviewing our past performance report. Make It Happen Click here to access our complete index of 2533 Asian Undiscovered Gems With Strong Fundamentals. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:688102 SZSE:300703 and SZSE:301293. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
10 minutes ago
- Bloomberg
Asia Set for Muted Start Ahead of Week of Key Data: Markets Wrap
Asian markets were poised for a cautious open as traders await key US and Chinese data and a possible extension to Beijing's tariff deadline. US equity futures were little changed in early trading and the dollar was in a tight range against major peers. Contracts indicate Australian and mainland Chinese shares may open little changed, with a gain in Hong Kong. Oil edged lower. Japan's markets are closed for a holiday.
Yahoo
31 minutes ago
- Yahoo
Here Are 3 Bullish Reasons Why JPMorgan Sees S&P 500 Rallying Much Higher
JPMorgan remains bullish on U.S. stocks even as some observers warn that the economy is beginning to pay the price for President Donald Trump's tariffs. The investment banking giant forecasts that the S&P 500, Wall Street's benchmark index, will yield a "high single-digit return over the next 12 months," driven by three key factors. One of the main reasons for optimism is that markets don't care about signs of an economic slowdown. Instead, traders are focused on resilient corporate earnings and the subsequent economic recovery. Since President Trump fired the first tariff salvo on April 2, economists have downgraded full-year U.S. growth forecasts from 2.3% to 1.5%. Still, the S&P 500 has gained over 28% in the four months. The index has held steady despite recent economic data revealing softness in the labour market and consumption, as well as stickiness in manufacturing and service sector inflation. While the macro analysts' warning is concerning and likely playing out in the background, corporate earnings in the U.S. are ignoring the slowdown risks, at least in the short term, making it the second catalyst for JPMorgan's bullish thesis. Over 80% of S&P 500 companies have recently reported their Q2 earnings, with 82% surpassing earnings expectations and 79% beating revenue forecasts—the strongest performance since the second quarter of 2021. The winners and losers According to JPMorgan, while Wall Street analysts initially projected earnings growth below 5%, the index is now on pace for an impressive 11% growth rate. This robust showing supports the ongoing bullish trend in the stock market. "The full-year earnings expectations for both this year and next have already started to turn higher," analysts at JPMorgan's wealth management said in a market note on Friday, adding that the market is increasingly differentiating between the winners and losers of the Trump trade war. Additionally, the market is now figuring out and pricing in which companies are getting hit most by U.S. tariffs. So far, it looks like mega corporations will be just fine. This could bolster the case for further positive sentiment in the markets. JPMorgan analysts explained that consumer-facing and smaller companies with restrained bargaining power against their trading partners and rigid supply chains are facing a stagnant earnings outlook. This ties to JPMorgan's last catalyst: Trump's tariff bark is proving worse than its bite for large firms, which are managing to secure exemptions and even turn the tariff policies, aimed at sparking a manufacturing boom, into a tailwind. "The latest example is President Donald Trump's suggestion that imported semiconductors would be taxed at a 100% rate unless the companies commit to relocating production to the United States. Another sign? Apple products are exempted from the latest tariff rates on Indian goods. Indeed, the company also announced an additional $100 billion investment in U.S. manufacturing facilities. The stock gained almost 9% this week. Tariffs are not happening in a vacuum," analysts explained. Big firms gain an additional advantage from the One Big Beautiful Act (OBBA), under which firms can claim 100% bonus depreciation for purchases of qualified business property and immediate expense of domestic research and development costs. According to some analysts, the depreciation policy could increase free cash flow for some by over 30%, which could incentivize more investment. The bank added that its investment strategy remains focused on large-cap equities, particularly in the technology, financials, and utilities sectors, which it believes are best positioned to navigate this new economic environment. The crypto angle JPMorgan's positive outlook for stocks could bode well for cryptocurrencies, as both tend to move in tandem. The digital assets market has plenty going on for itself, with the Trump administration appointing pro-crypto officials to key regulatory positions. Recently, the U.S. Securities and Exchange Commission (SEC) ruled that liquid staking, under certain conditions, falls outside the purview of Securities Law. The ruling has raised hopes for staking spot ether ETFs winning regulatory approval. Ether has rallied over 13% to over $4,200, reaching levels last seen in 2021. Prices surged nearly 50% last month, CoinDesk data show. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data